Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancer. - Archive ouverte HAL Access content directly
Journal Articles British Journal of Pharmacology Year : 2009

Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancer.

(1) , (2)
1
2

Abstract

The endogenous protein, tumour necrosis factor receptor apoptosis-inducing ligand (TRAIL), induces apoptosis in a wide variety of transformed and cancer cells but has little or no effect on normal cells. Therefore, TRAIL is considered to be a tumour-selective, apoptosis-inducing cytokine and a promising new candidate for cancer prevention and treatment. Some cancer cells are however resistant to TRAIL-induced apoptosis, but treatment in combination with conventional chemotherapeutic drugs or radiation generally restores TRAIL sensitivity in those cells. A novel class of molecules exhibiting synergy with TRAIL but devoid of major side effects are emerging as alternative approaches to treat resistant cancer cells, including natural antioxidants such as sulphoraphane or the flavonoids curcumin, quercetin, resveratrol, baicalein and wogonin. In this issue of the BJP, Lee et al. demonstrate that treatment of TRAIL-resistant cancer cells with wogonin restores TRAIL-induced cell death in a reactive oxygen species-dependent manner through up-regulation of p53 and Puma.
Fichier principal
Vignette du fichier
Rushworth_and_Micheau_commentary.pdf (80.3 Ko) Télécharger le fichier
Vignette du fichier
Scheme_final_Leuk.pdf (136.47 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-00527116 , version 1 (18-10-2010)

Identifiers

Cite

Stuart A. Rushworth, Olivier Micheau. Molecular crosstalk between TRAIL and natural antioxidants in the treatment of cancer.. British Journal of Pharmacology, 2009, 157 (7), pp.1186-8. ⟨10.1111/j.1476-5381.2009.00266.x⟩. ⟨inserm-00527116⟩
54 View
228 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More